Ahn, Chul Woo

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial

Hernandez, A. F., Green, J. B., Janmohamed, S., D'Agostino, R. B., Granger, C. B., Jones, N. P., Leiter, L. A., Rosenberg, A. E., Sigmon, K. N., Somerville, M. C., et al. (2018) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,829

Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea

Kang, E. S., Yun, Y. S., Park, S. W., Kim, H. J., Ahn, C. W., Song, Y. D., Cha, B. S., Lim, S. K., Kim, K. R., & Lee, H. C. (2005) · Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetes

Cited by 161

Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus

Kim, S. H., Lee, S. J., Kang, E. S., Kang, S., Hur, K. Y., Lee, H. J., Ahn, C. W., Cha, B. S., Yoo, J. S., & Lee, H. C. (2006) · Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 138

The effects of aerobic exercise training on serum osteocalcin, adipocytokines and insulin resistance on obese young males

Kim, Y., Nam, J. S., Yeo, D., Kim, K. R., Suh, S., & Ahn, C. W. (2015) · Clinical Endocrinology

Bone health and osteoporosis researchAdipokines, Inflammation, and Metabolic Diseases

Cited by 82

Smart care based on telemonitoring and telemedicine for type 2 diabetes care: Multi-center randomized controlled trial

Jeong, J. Y., Jeon, J.-H., Bae, K.-H., Choi, Y.-K., Park, K.-G., Kim, J.-G., Won, K. C., Cha, B. S., Ahn, C. W., Kim, D. W., et al. (2018) · Telemedicine and e-Health

Telemedicine and Telehealth ImplementationDiabetes Management and Research

Cited by 63

The Prevalence of the Metabolic Syndrome in Korean Adults: Comparison of WHO and NCEP Criteria

Choi, S. H., Ahn, C. W., Cha, B. S., Chung, Y.-S., Lee, K. W., Lee, H. C., Huh, K. B., & Kim, D. J. (2005) · Yonsei Medical Journal

Diabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and Disease

Cited by 48

Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus

Kim, Y. M., Cha, B. S., Kim, D. J., Choi, S. H., Kim, S. K., Ahn, C. W., Lim, S.-K., Kim, K. R., Huh, K. B., & Lee, H. C. (2005) · Diabetes Research and Clinical Practice

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 43

Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial

Kim, C. H., Han, K. A., Yu, J., Lee, S. H., Jeon, H. K., Kim, S. H., Kim, S. Y., Han, K. H., Won, K., Kim, D.-B., et al. (2018) · Clinical Therapeutics

Lipoproteins and Cardiovascular HealthFatty Acid Research and Health

Cited by 36

ROSIGLITAZONE RELIEVES ACUTE ETHANOL-INDUCED HANGOVER IN SPRAGUE–DAWLEY RATS

JUNG, T. W., LEE, J. Y., SHIM, W. S., KANG, E. S., KIM, S. K., AHN, C. W., LEE, H. C., & CHA, B. S. (2006) · Alcohol and Alcoholism

Alcohol Consumption and Health EffectsSubstance Abuse Treatment and Outcomes

Cited by 15